• HOME>
  • Investor Relations>
  • IR News>
  • Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

IR News

Mar. 01, 2018Print(PDF/175KB)Corporate

Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Masayo Tada) today announced that the following organizational realignment and changes in Executive Officers and other key positions, effective April 1, 2018:

I. Organizational Realignment (effective April 1, 2018)

Corporate Departments

Regenerative & Cellular Medicine Manufacturing Plant is established.

To coincide with the commencement of operations of an iPS-cell-derived cellular medicine manufacturing facility within Central Research Laboratories (Suita, Osaka) in March of 2018, Regenerative & Cellular Medicine Manufacturing Plant is established to supervise the facility. The organizations related to the business of regenerative and cellular medicine (Regenerative & Cellular Medicine Office, Regenerative & Cellular Medicine Kobe Center, Regenerative & Cellular Medicine Manufacturing Plant) promote early commercialization of the business through close coordination.

Furthermore, Japan Business Unit is established as a virtual organization, effective April 1. We aim to increase the business profitability in Japan through integrated operation of the Japan business by devising strategic units and investment units designed specifically for it. Japan Business Unit is comprised of the following organizations and consolidated subsidiaries.

Sales & Marketing (including DS Pharma Promo Co., Ltd.), Drug Development, Manufacturing, Corporate Regulatory Compliance & Quality Assurance, International Business Management, Regulatory Affairs, External Affairs, Medical Information, Medical Affairs

II. Changes in Executive Officers

(1) New Executive Officer (effective April 1, 2018)
Kazuhiro Takada (currently Sumitomo Pharmaceuticals (Suzhou) Co., Ltd.)

(2) Retiring Executive Officer (effective March 31, 2018)
Hajime Kinuta (currently Executive Officer Senior Director, Corporate Governance; Corporate Service Center)

(3) Changes in the positions assumed by Executive Officers (effective April 1, 2018)
Position as of April 1, 2018Current positionName
Member, Board of Directors, Senior Executive Officer Executive Director, Sales & Marketing Division
Head of Japan Business Unit
Member, Board of Directors, Senior Executive Officer
Executive Director, Sales & Marketing Division
Hitoshi Odagiri
Member, Board of Directors, Executive Officer
Senior Executive Research Director, Drug Research Division Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant
Member, Board of Directors, Executive Officer
Senior Executive Research Director, Drug Research Division Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center
Toru Kimura
Member, Board of Directors, Executive Officer
Executive Director, Corporate Regulatory Compliance & Quality Assurance Division; Regulatory Affairs; Medical Information; Medical Affairs; Drug Development Division
Deputy Head of Japan Business Unit
Member, Board of Directors, Executive Officer
Executive Director, Corporate Regulatory Compliance & Quality Assurance Division; Regulatory Affairs; Medical Information, Medical Affairs; Drug Development Division
Nobuyuki Hara
Senior Executive Officer Executive Director, Manufacturing Division; Technology Research & Development Division
Deputy Head of Japan Business Unit
Senior Executive Officer
Executive Director, Manufacturing Division; Technology Research & Development Division
Yoshiharu Ikeda
Executive Officer
Global Corporate Planning; Legal Affairs; Intellectual Property; IT Management & Digital Transformation
Executive Officer
Senior Director, Global Corporate Planning; Legal Affairs; Intellectual Property; IT Management & Digital Transformation
Hiroyuki Baba
Executive Officer
Corporate Governance (External Communications); Human Resources
Executive Officer
Corporate Governance (External Communications); Personnel (Diversification)
Atsuko Higuchi
Executive Officer
Global Business Development; International Business Management
Executive Officer
Senior Director, Global Business Development; International Business Management
Shigeyuki Nishinaka
Executive Officer
Senior Director, Corporate Governance; Corporate Service Center
Sumitomo Pharmaceuticals (Suzhou) Co., Ltd. Kazuhiro Takada

III. Changes in Personnel (effective April 1, 2018)

Corporate Departments
Position as of April 1, 2018Current positionName
Senior Strategic Officer - Management Accounting Strategic Officer - Management Accounting, Global Corporate Planning Yasushi Yukumatsu
Senior Director, Global Corporate Planning Senior Director, Clinical Research Yumi Sato
Senior Director, Global Business Development Senior Strategic Officer Ryoichi Urushihara
Senior Digital Officer Senior Director, IT Management & Digital Transformation Kyoichi Yokota
Senior Director, IT Management & Digital Transformation Director, IT Governance Group, IT Management & Digital Transformation Michio Nishida
Senior Director, Regenerative & Cellular Medicine Manufacturing Plant Regenerative & Cellular Medicine Office Kenji Komeda
Corporate Regulatory Compliance & Quality Assurance (Division)
Position as of April 1, 2018Current positionName
Senior Medical Officer, Safety Physician Senior Advisor, Pharmacovigilance Chie Kuragaki
Senior Director, Clinical & Research Quality Assurance Director, Safety Coordination Group, Pharmacovigilance Michie Kuroda
Drug Development (Division)
Position as of April 1, 2018Current positionName
Senior Fellow, CNS Clinical Development CNS Fellow, Clinical Research Kazuki Yabuuchi
Senior Director, Development Planning & Management Sunovion Pharmaceuticals Inc. Itaru Shinohara
Senior Director, Clinical Research Director, Project Management, Development Planning & Management Katsunori Maruta
Sales & Marketing (Division)
Position as of April 1, 2018Current positionName
Senior Director, Product Management & Promotion Planning Senior Director, Kobe Branch Masayuki Mukai
Senior Director, CNS Product Management & Promotion Planning Senior Director, Chiba Branch Tsuneharu Inoue
Senior Director, Sapporo Branch Director, Wholesaler Service Group, Chugoku Branch
Director, Wholesaler Service Group, Shikoku Branch
Manabu Tatsukawa
Senior Director, Tohoku Branch Senior Director, Saitama Branch Haruo Kusakabe
Senior Director, Koshinetsu Branch Sales Officer, Tokyo Branch Katsuhiko Nishida
Senior Director, Chiba Branch Senior Director, Koshinetsu Branch Yoshito Yamashita
Senior Director, Saitama Branch Director, Nagoya Group Ⅱ, Hospital Promotion, Tokai Branch Yasunori Shiroyama
Senior Director, Tokyo Branch Senior Director, Tokyo Branch
Deputy Senior Director, Hospital Promotion, Tokyo Branch
Motohide Takahara
Senior Director, Tokai Branch Senior Director, Shikoku Branch Yasushi Miyauchi
Senior Director, Osaka Branch Senior Director, Osaka Branch
Deputy Senior Director, Hospital Promotion, Osaka Branch
Masaichi Fujimoto
Senior Director, Kobe Branch Director, Planning & Management Group, Distribution Management Noboru Hirata
Senior Director, Chugoku Branch Deputy Senior Director, Hospital Promotion, Tokai Branch Hidekatsu Kuroda
Senior Director, Shikoku Branch Director, Product Group Ⅰ, Product Management & Promotion Planning Takafumi Ishibashi
Senior Director, Kyushu Branch Senior Director, Kyushu Branch
Deputy Senior Director, Hospital Promotion, Kyushu Branch
Koji Yamazaki
Manufacturing (Division)
Position as of April 1, 2018Current positionName
Deputy Executive Director, Manufacturing Division
Senior Director, Suzuka Plant Deputy Senior Director, Quality Assurance, Suzuka Plant
Deputy Executive Director, Manufacturing Division
Senior Director, Suzuka Plant
Hotaka Hashimoto